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1318 The Journal of Thoracic and CardObjective: The primary limitation of the American Heart Association/American
College of Cardiology guidelines is specificity. To improve the selection process,
we proposed a simple additive model including age (1 point for every 5 years above
50), male sex (2 points), hypercholesterolemia (2 points), angina (3 points), and
electrocardiographic evidence of ischemia (3 points). We recommend screening
angiography at 3 or more points. This model was previously derived from 359
patients at Papworth Hospital.
Methods: The validation cohort was a consecutive series of patients who underwent
mitral valve surgery at the Royal Brompton Hospital. Preoperative coronary an-
giography reports were obtained, and coronary disease was defined as luminal
narrowing of 50% in 2 or more views. Sensitivities and specificities were calculated
for the American Heart Association/American College of Cardiology criteria, the
simple additive model, and a logistic regression model. Receiver operating charac-
teristic curves were used to validate accuracy and compare discrimination with
logistic regression.
Results: From 1998 through 2003, angiographic details were available for 342
(86%) of 396 patients who underwent mitral valve surgery. The sensitivity and
specificity of the American Heart Association/American College of Cardiology
guidelines were 100% and 5%, respectively; those of the simple additive model
were 91% and 44%, respectively; and those of logistic regression were 93% and
41%, respectively. The receiver operating characteristic areas for the simple additive
and logistic regression model were 0.78 (95% confidence interval, 0.73-0.84) and
0.80 (95% confidence interval, 0.74-0.85), respectively.
Conclusions: This is the third independent cohort to highlight the poor specificity of
the American Heart Association/American College of Cardiology guidelines. Al-
though high sensitivity is achieved, the cost is the majority of patients requiring
screening angiography. Our validated simple model improved the specificity and
selection; however, this was achieved at the expense of decreased sensitivity.
Screening for coexistent coronary disease remains an important aspect of theassessment of patients before mitral valve surgery. Coronary and mitral valvedisease are inextricably linked as a causative agent for mitral valve disease
(eg, ischemic mitral regurgitation), a coexistent agent that modifies operative
strategy (eg, concomitant coronary disease in patients with degenerative mitral
valve disease), and an adverse prognostic predictor of survival.1
The primary limitation of the widely used American Heart Association/American
College of Cardiology (AHA/ACC) guidelines2 is specificity (previously estimated
3 at 1%). The inability to accurately rule in coexistent coronary disease (the selection
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CDprocess) leads to almost universal recommendation for pre-
operative screening angiography.
A number of proposals have been made to improve
selection criteria and increase the discriminatory ability
achieved with sophisticated statistical models.4 Although
mathematically accurate, they are difficult to implement at
the bedside or consulting room. In 2003, we proposed a
simple additive model derived from a cohort of patients in
Cambridge, with the following 5 variables: age (1 point for
every 5 years above 50), male sex (2 points), hypercholes-
terolemia (2 points), angina (3 points), and electrocardio-
graphic evidence of ischemia (3 points). We recommend
screening angiography at 3 or more points.
The aim of this study was to validate and assess the
discriminatory value of our simple additive model on a
different cohort of patients who underwent mitral valve
surgery at the Royal Brompton Hospital in London, United
Kingdom.
Methods
The validation cohort was identified from a database of a consec-
utive series of patients who underwent mitral valve surgery from
1998 through 2003 at the Royal Brompton Hospital in a 3-surgeon
series (J.P., A.D.S., and N.M.). Reports from preoperative screen-
ing coronary angiography were obtained from patients listed for
elective mitral valve surgery. Experienced cardiologists had re-
TABLE 1. Baseline characteristics*
Sample size 342
Mean (SD) age, y 65 (11)
Male sex 194 (57)
Diabetes 6 (2)
Hypercholesterolemia 51 (15)
Smoker 125 (37)
Family history of IHD 34 (10)
Angina 7 (2)
Previous myocardial infarction, n (%) 8 (2)
ECG evidence of ischemia 5 (1)
NYHA class III-IV 199 (58)
Cause of mitral valve disease
Degenerative 226 (66)
Rheumatic 64 (19)
Ischemic 18 (5)
Endocarditis 10 (3)
Other† 22 (7)
Mitral valve repair 182 (61)
Mitral valve replacement 114 (39)
Any coronary disease 82 (24)
Concomitant coronary bypass surgery 69 (20)
IHD, Ischemic heart disease; ECG, electrocardiography; NYHA, New York
Heart Association. *All data except age are presented as numbers (per-
centages). †Other includes revision operations and congenital mitral valve
disease.viewed the coronary angiograms, and the degree of luminal nar-
The Journal of Thoracicrowing was obtained by means of visual estimation. The presence
of significant coronary disease was defined as luminal narrowing
of 50% in 2 or more views.
Risk factors for coronary artery disease were defined as fol-
lows: age (35 years for men and 51 years for women), family
history (first-degree relative with a myocardial infarction before
the age of 50 years in men and 60 years in women), smoking,
diabetes, and hypercholesterolemia (defined as receiving medica-
tion for hypercholesterolemia or serum cholesterol of 5.0
mmol/L [193 mg/dL]). Evaluated AHA/ACC indications were a
history of angina or myocardial infarction or the presence of one or
more risk factors for coronary artery disease. The presence of
ischemic changes on echocardiography was defined as any resting
ST-segment or T-wave abnormality. The cause of mitral regurgi-
tation was determined by means of operative assessment in con-
junction with histopathologic examination of valve specimens.
Statistical methodology for the development of our simple
additive model (from logistic regression analysis) has been previ-
ously described.3 Sensitivities and specificities were calculated for
the AHA/ACC criteria, our simple additive model, and a logistic
regression model. Receiver operating characteristic (ROC) curves
were used to validate the accuracy of our simple additive model
and also to compare the discrimination of our model with that of
a full logistic regression model derived by Lin and colleagues4
from the Cleveland Clinic (both models are detailed in the
Appendix).
Results
From January 1, 1998, to January 1, 2003, a total of 396
patients underwent mitral valve surgery. Angiographic de-
TABLE 2. Sensitivity and specificity of AHA/ACC criteria,
the simple additive model, and full logistic regression (Lin
and colleagues4)
Sensitivity
(95% CI)
Specificity
(95% CI)
AHA/ACC criteria 100% (100.0-100.0) 5% (2.9-7.6)
Simple additive model 91% (88.5-94.4) 44% (39.2-49.6)
Full logistic regression 93% (90.0-95.4) 41% (35.9-46.2)
AHA/ACC, American Heart Association/American College of Cardiology.
TABLE 3. Utility of the different models to predict coexis-
tent coronary disease
No. (%) not
requiring
angiography
No. (%) of
missed coronary
disease*
AHA/ACC criteria 12 (3.5) 0 (0)
Simple additive model 123 (36.0) 7 (2.0)
Logistic regression 113 (33.0) 6 (1.8)
AHA/ACC, American Heart Association/American College of Cardiology.
*The percentages of missed coronary disease are expressed as a total of
the cohort and not as a proportion of patients who did not require
angiography because the aim is to evaluate the effect of the population-
based approach on unselected patients.
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CDtails were unavailable for 54 (14%) patients, 41 with and 13
without AHA/ACC-defined indications, leaving 342 pa-
tients. The validation cohort had a mean (SD) age of 65 (11)
years, and a total of 182 (61%) had mitral valve repair, and
114 (39%) had mitral valve replacement (Table 1).
The sensitivities and specificities of the AHA/ACC
guidelines were 100% and 5%, respectively; those of the
simple additive model were 91% and 44%, respectively;
and those of the logistic regression model were 93% and
41%, respectively (Tables 2 and 3).
The area under the ROC curves for the simple additive
and logistic regression models were 0.78 (95% confidence
interval [CI], 0.73-0.84) and 0.80 (95% CI, 0.74-0.85),
respectively (Figure 1).
Discussion
This is now the third study (in 3 independent patient pop-
ulations) that highlight the limitations of the AHA/ACC
selection criteria for recommendations of preoperative
screening angiography in patients before mitral valve sur-
gery.3,4 The intrinsic problem lies in specificities that ranged
from 1% to 5%, the latter achieved in this study. Our results
demonstrate that it is possible to increase the specificity of
the screening guidelines to 44% with more sophisticated
statistical modeling. The results from our simple additive
model, derived from logistic regression analysis and de-
signed to be able to be used at the bedside without the
requirement of a calculator, were comparable with predic-
Figure 1. ROC curves of the simple additive and logistic regres-
sion models.tion with full logistic regression analysis.
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the criteria for screening coronary angiography, a procedure
that carries a 1.7% risk of major complication, including a
0.11% risk of death, a 0.05% risk of myocardial infarction,
and a 0.07% risk of stroke.5 Although the absolute risk
increment itself might seem low, the low specificity of
current AHA/ACC screening guidelines results in the vast
majority of patients meeting the criteria. Therefore substan-
tial mortality and morbidity might be experienced on a
population basis when large numbers are exposed to these
“low” risks.
The effect on cost-benefit analysis with improved selec-
tion has been considered previously by Lin and colleagues.4
Before consideration of finances, we would be more con-
cerned in determining the effect of missing patients with
potentially treatable coronary disease, and there is (not
surprisingly) little in the literature to help guide this
decision-making process. It is conceivable that a potential
range of outcomes would include neither harm nor postop-
erative angina (no flow-limiting disease), residual postop-
erative angina, or inability to wean from cardiopulmonary
bypass after surgical intervention, resulting in death. What
price could possibly be attached to the (as yet unquantifi-
able) risk of death as a result of missing patients with
potentially treatable coronary disease?
Where Is the Balance?
As we attempt to improve the specificity of the current
AHA/ACC guidelines (to reduce the morbidity of patients
undergoing unnecessary coronary angiography), we will
inevitably reduce the sensitivity of the selection process
(miss patients with potentially treatable coronary disease).3
This is due to the statistical properties of the relationship
between sensitivity and specificity; as one increases, the
other decreases, and vice versa.6
The guidelines of the AHA/ACC do not miss any pa-
tients with coexistent coronary disease (100% sensitivity),
but this is achieved by almost universal recommendations
for screening angiography (low specificity) and unnecessar-
ily exposing patients to the risks of coronary angiography;
as such, achieving the balance in this situation is extremely
difficult. If the aim is not to miss any patients with coexis-
tent coronary disease, then the AHA/ACC guidelines are
successful in this regard. However, similar results can also
be achieved by using age over 35 years alone as the sole
indication (sensitivity, 100% [95% CI, 100.0%-100.0%];
specificity, 0.38% [95% CI, 0.0%-1.0%]), and detailed
guidelines might not be required.
A similar but extreme counterargument, for example,
would be to increase the specificity by performing angiog-
raphy only on patients with a history of myocardial infarc-
tion, where the sensitivity would be close to 100% (allowing
for misdiagnosis of myocardial infarction). However, this
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(missing patients with coronary disease).
Therefore the balance does not rely on a test that would
favor individual sensitivity or specificity but rather an ap-
proach that takes the balance of both into account. The crux
of the argument lies in the individual surgeon’s opinion of
the (unquantifiable) risks of untreated coronary disease
weighted against the (known) risks of morality, morbidity,
and cost associated with screening angiography in the ma-
jority (76% in this series) of patients who undergo mitral
valve surgery without coexistent coronary disease.
Potential Limitations
In this study we have used the model of Lin and colleagues4
on an unselected cohort undergoing mitral valve surgery; its
design and use was in patients with degenerative disease.
However, when applied solely to the patients with degen-
erative disease in our cohort, the discriminating ability was
similar (area under the ROC curve, 0.79 [95% CI, 0.71-
0.87]).
Of the 7 patients without indications in the simple model
for coronary angiography, 4 had single-vessel and 3 had
double-vessel disease. Of the 6 patients without indications
in the logistic regression model, 4 had single-vessel, 1 had
double-vessel, and 1 had triple-vessel disease. It is impor-
tant to note, however, that neither statistical model takes
into account disease severity but merely the presence of
significant coronary disease.
Conclusion
The high sensitivity of the AHA/ACC guidelines for screen-
ing angiography to detect coexistent coronary disease in
patients before mitral valve surgery is achieved at a cost of
poor specificity and results in the majority of patients re-
quiring screening angiography. Our validated simple model
has the discriminating ability of a more complex logistic
regression model with the advantage of being easily imple-
mented at the bedside and improved specificity over the
AHA/ACC recommendations. This (and usually in other
statistical models) is achieved by sacrificing sensitivity and
carries the risk of missing patients with coexistent coronary
disease.
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Appendix. Criteria for the simple additive and
logistic regression model
Appendix TABLE 1. Simple additive model3
Variable Score
Age 1 point for each 5 years over
the age of 50 years
Male sex 2 points
Hypercholesterolemia 2 points
Angina 3 points
ECG evidence of ischemia 3 points
Angiography is recommended for a score of 3 or more. ECG,
Electrocardiography.
Appendix TABLE 2. Logistic regression model of Lin et al4
Model score (Ln OR)  (0.105  Age)  (1.177  Male sex)
 (1.475  Diabetes mellitus)  (1.750  Hyperlipidemia)
 (0.483  Hypertension)  10.070
Angiography is recommended for a risk of greater than 5% (model score of
more than 2.95).
and Cardiovascular Surgery ● Volume 129, Number 6 1321
